Tracked deals
4
4 tracked deals across 2023-2025.
Operating Company
Healthcare
SAI MedPartners
Reading, Pennsylvania, United States
SAI MedPartners guides clinical and commercial strategy development by providing decision support and advisory services to biopharmaceutical, medical device, and allied healthcare organizations, leveraging competitive intelligence, path-to-market strategy and positioning, syndicated reports, and market research.
- Focus Areas
- Competitive Intelligence, Market Intelligence, Syndicated Reports
- Website
- www.sai-med.com
Recent pace
1
1 tracked deal announced in the last 12 months.
Deal mix
Addon
4 addon
SAI MedPartners Acquisition Volume by Year
Last 3 years
Supporting Data
Recent Transactions
-
December 4, 2025
- Buyer
- SAI MedPartners
- Target
- The Dunn Group
- Industry
- Healthcare Services
- Location
- New Jersey, United States
- Type
- Addon
SAI MedPartners, a Northlane Capital Partners-backed healthcare consultancy, has acquired The Dunn Group, a Totowa, New Jersey-based competitive intelligence firm focused on pharmaceuticals, biotechnology, and medical devices. The acquisition expands SAI's competitive intelligence capabilities and deepens its life sciences market research and analytics offerings.
-
November 14, 2024
- Buyer
- SAI MedPartners, Northlane Capital Partners
- Target
- IDEA Pharma
- Industry
- Healthcare Services
- Location
- United Kingdom
- Type
- Addon
SAI MedPartners, a global life-sciences consultancy backed by Northlane Capital Partners, has acquired London-headquartered IDEA Pharma to strengthen its pharmaceutical path-to-market, clinical development, and commercialization capabilities. The acquisition is an add-on to SAI's platform, expanding its strategic services offering to biopharma and medical device clients.
-
March 29, 2023
- Buyer
- SAI MedPartners
- Target
- PharmaForce International
- Industry
- Healthcare Services
- Location
- Pennsylvania, United States
- Type
- Addon
SAI MedPartners, a consultancy focused on strategic insights and analytics for the pharmaceutical, biotech, and medical device industries, has acquired PharmaForce International, a Reading, Pennsylvania–based market intelligence and syndicated research firm. The acquisition adds PharmaForce's commercial benchmarking and syndicated research capabilities to SAI's competitive intelligence offerings; SAI is PE-backed by Northlane Capital Partners (which partnered with management to acquire SAI in June 2022).
-
January 4, 2023
- Buyer
- SAI MedPartners, Northlane Capital Partners
- Target
- Fulcrum Research Group
- Industry
- Healthcare Services
- Location
- Massachusetts, United States
- Type
- Addon
SAI MedPartners, a consultancy backed by Northlane Capital Partners, has acquired Fulcrum Research Group, a Waltham, MA-based primary market research firm focused on healthcare and biopharma. The add-on expands SAI's strategic insights and primary research capabilities to better serve pharmaceutical, biotechnology, and medical device clients.
Related Acquisition Pages
Selling a company? Get in front of buyers like SAI MedPartners
Turn tracked acquisition activity into an outreach-ready buyer list.